Michel Mittelbronn

8PUBLICATIONS
75CO-AUTHORS
Cancer cell biologyMedical infection agents (incl. prions)Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 22, 2025
Fusobacterium nucleatum interacts with cancer-associated fibroblasts to promote colorectal cancer.

Jessica Karta, Marianne Meyers, Fabien Rodriguez

|Feb 15, 2025
Microglia aggregates define distinct immune and neurodegenerative niches in Alzheimer's disease hippocampus.

Sonja Fixemer, Mónica Miranda de la Maza, Gaël Paul Hammer

|Mar 13, 2024
Impact of Formalin- and Cryofixation on Raman Spectra of Human Tissues and Strategies for Tumor Bank Inclusion.

Giulia Mirizzi, Finn Jelke, Michel Pilot

|Jul 20, 2023
Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment.

Markus Haake, Beatrice Haack, Tina Schäfer

|May 15, 2023
Effects of Minocycline Hydrochloride as an Adjuvant Therapy for a Guided Bone Augmentation Procedure in The Rat Calvarium.

Bob Biewer, Eric Rompen, Michel Mittelbronn

|Mar 22, 2023
Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts.

Yahaya A Yabo, Pilar M Moreno-Sanchez, Yolanda Pires-Afonso

Pageof 2

Frequent Collaborators

3 joint publications

Felix Kleine-Borgmann

2 joint publications

Eric Rompen

2 joint publications

Gaël Paul Hammer

2 joint publications

Mohaned Benzarti